Yang, W. Et Al. 2019. Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.150 , 158-166.

Yang, W., ERSOY, C., Wang, G., Ye, S., Liu, J., Miao, H., ... Asirvatham, A.(2019). Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.150, 158-166.

Yang, Wenying Et Al. "Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.150, 158-166, 2019

Yang, Wenying Et Al. "Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.150, pp.158-166, 2019

Yang, W. Et Al. (2019) . "Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.150, pp.158-166.

@article{article, author={Wenying Yang Et Al. }, title={Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2019, pages={158-166} }